RAF1 and breast cancer: In breast cancer (BC) cells, EZH2 promotes expansion of TICs and mammosphere formation through activation of RAF1/β-catenin signaling [69,70], while in glioblastoma loss of H3K27me3 can lead to aberrant Wnt signaling activation, which is necessary for maintenance of CSCs [71].